Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
Dhanya Kalathil, Samu John, S. Asha Nair
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition
David Gallo, Jordan T.F. Young, Jimmy Fourtounis, et al.
Nature (2022) Vol. 604, Iss. 7907, pp. 749-756
Open Access | Times Cited: 131
Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials
Sajad Najafi
International Journal of Biological Macromolecules (2022) Vol. 206, pp. 939-953
Closed Access | Times Cited: 73
FOXM1: A small fox that makes more tracks for cancer progression and metastasis
Md Arafat Khan, Parvez Κhan, Aatiya Ahmad, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 1-15
Open Access | Times Cited: 57
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
Cassie Liu, Carter J. Barger, Adam R. Karpf
Cancers (2021) Vol. 13, Iss. 12, pp. 3065-3065
Open Access | Times Cited: 72
FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD‐L1 Expression and Cell Proliferation
Hamadi Madhi, Jeon‐Soo Lee, Young Eun Choi, et al.
Advanced Science (2022) Vol. 9, Iss. 29
Open Access | Times Cited: 56
Heat shock proteins and cancer: The FoxM1 connection
Zahra Alimardan, Maryam Abbasi, Farshid Hasanzadeh, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115505-115505
Open Access | Times Cited: 23
A novel peptide CP29L, selected from the phage displayed cyclic random heptapeptide library, demonstrates its potent inhibitory effects to liver cancer HCCLM3 cells by targeting FOXM1
Xinyi Hua, Kun Xiang, Anping Liang, et al.
European Journal of Pharmacology (2025), pp. 177246-177246
Closed Access | Times Cited: 1
Non-coding RNAs as mediators of epithelial - Mesenchymal transition (EMT) in metastatic colorectal cancers
Aisha Shigna Nadukkandy, Britny Blaize, C. Selvaa Kumar, et al.
Cellular Signalling (2025) Vol. 127, pp. 111605-111605
Closed Access | Times Cited: 1
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Maria Serena Roca, Tania Moccia, Federica Iannelli, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 31
FOXM1 regulates glycolysis and energy production in multiple myeloma
Yan Cheng, Fumou Sun, Krista Thornton, et al.
Oncogene (2022) Vol. 41, Iss. 32, pp. 3899-3911
Open Access | Times Cited: 28
Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment
Ángela Patricia Moreno-Londoño, Martha Robles‐Flores
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 25-51
Open Access | Times Cited: 20
PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities
Mohammed Ageeli Hakami, Ali Hazazi, Farhan R. Khan, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155019-155019
Closed Access | Times Cited: 20
Discovery of Potent and Novel Dual PARP/BRD4 Inhibitors for Efficient Treatment of Pancreatic Cancer
Shu-Ping Wang, Yu Li, Shihui Huang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 17413-17435
Closed Access | Times Cited: 35
MicroRNA-383: A tumor suppressor miRNA in human cancer
Abdollah Jafarzadeh, Majid Noori, Shaghayegh Sarrafzadeh, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 25
FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells
Hisashi Takeshita, Ryoji Yoshida, Junki Inoue, et al.
Laboratory Investigation (2023) Vol. 103, Iss. 5, pp. 100060-100060
Open Access | Times Cited: 13
Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
Sanjeev Raghuwanshi, Andrei L. Gartel
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189015-189015
Closed Access | Times Cited: 13
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
FDI-6 inhibits the expression and function of FOXM1 to sensitize BRCA-proficient triple-negative breast cancer cells to Olaparib by regulating cell cycle progression and DNA damage repair
Shu-Ping Wang, Shiqi Wu, Shihui Huang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 12
Open Access | Times Cited: 29
A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics
Yanling Zhang, Yan Ma, Youqin Zeng, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 22, pp. 1704-1704
Open Access | Times Cited: 27
TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC
Salvina Laura Tammaccaro, Philippe Prigent, Jean-Christophe Le Bail, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 553-553
Open Access | Times Cited: 12
The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors
Xavier T.R. Moore, Lilia Gheghiani, Zheng Fu
Cells (2023) Vol. 12, Iss. 9, pp. 1344-1344
Open Access | Times Cited: 11
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Muhammad Yasir, Jin‐Young Park, Wanjoo Chun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15173-15173
Open Access | Times Cited: 11
Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy
Mo-Fan Huang, Yuanxin Wang, Yu‐Ting Chou, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1558-1558
Open Access | Times Cited: 4
NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells
Cassie Liu, Makenzie Vorderbruggen, Catalina Muñoz-Trujillo, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
Yi Yao, Yu Zhong, Lu Xie, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top